Authors: Ogilvie, ALJ Antoni, C Dechant, C Manger, B Kalden, JR Schuler, G Luftl, M

Citation: Alj. Ogilvie et al., Treatment of psoriatic arthritis with antitumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate, BR J DERM, 144(3), 2001, pp. 587-589

Authors: Kraetsch, HG Antoni, C Kalden, JR Manger, B

Citation: Hg. Kraetsch et al., Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences, ANN RHEUM D, 60, 2001, pp. III55-III57

Authors: Lorenz, HM Grunke, M Hieronymus, T Antoni, C Nusslein, H Schaible, TF Manger, B Kalden, JR

Citation: Hm. Lorenz et al., In vivo blockade of tumor necrosis factor-alpha in patients with rheumatoid arthritis: Longterm effects after repeated infusion of chimeric monoclonal antibody cA2, J RHEUMATOL, 27(2), 2000, pp. 304-310

Authors: Antoni, C Kalden, JR

Citation: C. Antoni et Jr. Kalden, Combination therapy of the chimeric monoclonal anti-tumor necrosis factor alpha antibody (infliximab) with methotrexate in patients with rheumatoid arthritis, CLIN EXP RH, 17(6), 1999, pp. S73-S77

Authors: Charles, P Elliott, MJ Davis, D Potter, A Kalden, JR Antoni, C Breedveld, FC Smolen, JS Eberl, G deWoody, K Feldmann, M Maini, RN

Citation: P. Charles et al., Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis, J IMMUNOL, 163(3), 1999, pp. 1521-1528